Label: MEIJER SENNA LAXATIVE REGULAR STRENGTH- sennosides tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated October 17, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient (in each tablet)

    Sennosides 8.6 mg

  • Purpose

    Laxative

  • Uses

    ▪
    relieves occasional constipation (irregularity)
    ▪
    generally produces a bowel movement within 6- 12 hours.
  • Warnings

    Do not use

    ▪
    laxative products for longer than 1 week unless directed by a doctor

    Ask a doctor before use if you have

    ▪
    stomach pain
    ▪
    nausea
    ▪
    vomiting
    ▪
    noticed a sudden change in bowel habits that continues over a period of 2 weeks.

    Stop use and ask a doctor if

    you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

    If pregnant or breast-feeding,

    ask a health professional before use.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right immediately at 1-800-222-1222.

  • Directions

    ▪
    take preferably at bedtime or as directed by a doctor

    age

    starting dosage 

    maximum dosage 

    adults and children 12 years of age and over 

    2 tablets once a day 

    4 tablets twice a day 

    children 6 to under 12 years 

    1 tablet once a day 

    2 tablets twice a day 

    children 2 to under 6 years 

    1/2 tablet once a day 

    1 tablet twice a day 

    children under 2 years 

    ask a doctor 

    ask a doctor 
  • Other information

    ▪
    store at room temperature
  • Inactive Ingredients

    Croscarmellose sodium, dicalcium phosphate, Hypromellose, maltodextrin, microcrystalline cellulose, magnesium stearate, paraffin liquid, silicon dioxide, sodium lauryl sulphate, stearic acid.

  • Questions or comments?

    Call 1-866-467-2748

  • Principal Display Panel

    NDC# 41250-445-00

    *Compare to the active ingredient of Senokot®

    Senna Laxative

    Standardized Senna Concentrate

    Regular Strength

    Natural Vegetable Laxative Ingredient

    Gentle, dependable

    Overnight relief

    100 Tablets

    *This product is not manufactured or distributed by Avrio Health L.P., owner of the registered trademark Senokot®.

    TAMPER EVIDENT: DO NOT USE IF PRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

    DIST. BY MEIJER DISTRIBUTION, INC.

    GRAND RAPIDS, MI 49544

    www.meijer.com

  • Product Label

    Meijer Senna Laxative Standardized Senna Concentrate

    Meijer Senna Laxative

  • INGREDIENTS AND APPEARANCE
    MEIJER SENNA LAXATIVE  REGULAR STRENGTH
    sennosides tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:41250-445
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
    Inactive Ingredients
    Ingredient NameStrength
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)  
    HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    MINERAL OIL (UNII: T5L8T28FGP)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    Product Characteristics
    ColorBROWNScoreno score
    ShapeROUNDSize9mm
    FlavorImprint Code RP117
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:41250-445-001 in 1 BOX04/20/2020
    1100 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00704/20/2020
    Labeler - MEIJER, INC. (006959555)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!